Novel therapy for children with chronic hormone deficiency provides lifeline for parents

Apr 12, 2019

  • Alkindi® is the first replacement therapy specially designed for infants, children and adolescents with paediatric adrenal insufficiency
  • Adrenal insufficiency is caused by a lack of the stress hormone cortisol – which can be fatal
  • This new therapy, which has been developed by University of Sheffield spin-out company Diurnal, has been granted market authorisation by the European Medicine Agency.

Read more

Recent Blog Posts

What you should know about COVID-19 – updated 10th August 2021

What you should know about COVID-19 – updated 10th August 2021

Guidance from other organizations is continually being issued and we'll do our best to link to them below - please keep checking back here for more updates. UPDATE 10th August 2021 Article: “ChAdOx1 SARS‐CoV‐2 vaccination: A putative precipitant of adrenal crises”...

Fundraiser in aid of Living with CAH & 120Marathonman Charities

Fundraiser in aid of Living with CAH & 120Marathonman Charities

The last week of Marathonman is here - almost 120 marathons completed For more information, see the link below. Join Graham Wilson and his fantastic team in as many or as few steps as you would like to. He will walk an average of 60,000 steps per marathon giving a...